Trial Profile
Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2013
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 06 Nov 2013 New trial record